First Foundation Advisors’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-3,090
Closed -$292K 361
2019
Q1
$292K Buy
+3,090
New +$270K 0.02% 270
2018
Q1
Sell
-25,127
Closed -$2.62M 363
2017
Q4
$2.62M Sell
25,127
-54
-0.2% -$6.09K 0.14% 96
2017
Q3
$3.67M Buy
25,181
+490
+2% +$66.7K 0.21% 74
2017
Q2
$3.21M Buy
24,691
+607
+3% +$74.4K 0.19% 75
2017
Q1
$3M Sell
24,084
-64
-0.3% -$7.66K 0.19% 81
2016
Q4
$2.79M Sell
24,148
-690
-3% -$76.8K 0.18% 92
2016
Q3
$2.6M Buy
24,838
+380
+2% +$41.1K 0.18% 87
2016
Q2
$2.41M Hold
24,458
0.17% 86
2016
Q1
$2.45M Sell
24,458
-723
-3% -$74.4K 0.18% 81
2015
Q4
$3.02M Buy
+25,181
New +$2.91M 0.21% 80

Other funds holding CELG

First Foundation Advisors's CELG Position: Q2 2019 in Review

First Foundation Advisors sold out of Celgene Corp (CELG) in Q2 2019, closing a stake of 3,090 shares — an estimated $292K sold.

First Foundation Advisors first reported a position in CELG in Q4 2015 and held it in 10 quarters. The position peaked at $3.67M in Q3 2017. 1,287 funds tracked by Wall St. Rank hold CELG as of Q2 2019.

  • First Foundation Advisors reported no remaining Celgene Corp position as of Q2 2019 after selling out during the quarter.
  • First Foundation Advisors sold 3,090 Celgene Corp shares in Q2 2019, an estimated $292K.
  • First Foundation Advisors first reported a position in Celgene Corp in Q4 2015 and held it in 10 quarters.
  • First Foundation Advisors's Celgene Corp position peaked at $3.67M in Q3 2017.
  • 1,287 funds tracked by Wall St. Rank held Celgene Corp as of Q2 2019.

Based on First Foundation Advisors's 13F filing for Q2 2019, filed 14 Aug 2019.